https://www.reasonably-accountable.com/tag/adverse-events/2026-09-10T11:53:02.000Zhttps://www.reasonably-accountable.com/tag/guideline-development/2026-09-10T11:38:51.000Zhttps://www.reasonably-accountable.com/tag/finerenone/2026-09-10T11:36:18.000Zhttps://www.reasonably-accountable.com/tag/spironolactone/2026-09-10T11:36:18.000Zhttps://www.reasonably-accountable.com/tag/ta1182/2026-09-10T11:36:18.000Zhttps://www.reasonably-accountable.com/tag/heart-failure/2026-09-10T11:36:18.000Zhttps://www.reasonably-accountable.com/tag/dapagliflozin/2026-09-10T11:36:18.000Zhttps://www.reasonably-accountable.com/tag/empagliflozin/2026-09-10T11:36:18.000Zhttps://www.reasonably-accountable.com/tag/mineralocorticoid-receptor-antagonist/2026-09-10T11:36:18.000Zhttps://www.reasonably-accountable.com/tag/meta-analysis/2026-09-10T11:36:18.000Zhttps://www.reasonably-accountable.com/tag/kerendia/2026-09-10T11:36:18.000Zhttps://www.reasonably-accountable.com/tag/bayer/2026-09-10T11:36:18.000Zhttps://www.reasonably-accountable.com/tag/sodium-glucose-co-transporter-2/2026-09-10T11:36:18.000Zhttps://www.reasonably-accountable.com/tag/steroidal/2026-09-10T11:36:18.000Zhttps://www.reasonably-accountable.com/tag/ng106/2026-09-10T11:36:18.000Zhttps://www.reasonably-accountable.com/tag/value-of-information/2026-09-10T11:36:18.000Zhttps://www.reasonably-accountable.com/tag/indirect-treatment-comparison/2026-09-10T11:36:18.000Zhttps://www.reasonably-accountable.com/tag/nice/2026-08-20T21:07:37.000Zhttps://www.reasonably-accountable.com/tag/ta1181/2026-08-20T21:07:37.000Zhttps://www.reasonably-accountable.com/tag/aficamten/2026-08-20T21:07:37.000Zhttps://www.reasonably-accountable.com/tag/mavacamten/2026-08-20T21:07:37.000Zhttps://www.reasonably-accountable.com/tag/cost-comparison/2026-08-20T21:07:37.000Zhttps://www.reasonably-accountable.com/tag/resource-impact/2026-08-20T21:07:37.000Zhttps://www.reasonably-accountable.com/tag/itc/2026-08-20T21:07:37.000Zhttps://www.reasonably-accountable.com/tag/independent-treatment-comparison/2026-08-20T21:07:37.000Zhttps://www.reasonably-accountable.com/tag/mhra/2026-08-20T21:07:37.000Zhttps://www.reasonably-accountable.com/tag/hypertrophic-cardiomyopathy/2026-08-20T21:07:37.000Zhttps://www.reasonably-accountable.com/tag/cardiovascular/2026-08-20T21:07:37.000Zhttps://www.reasonably-accountable.com/tag/echocardiography/2026-08-20T21:07:37.000Zhttps://www.reasonably-accountable.com/tag/cytokinetics/2026-08-20T21:07:37.000Zhttps://www.reasonably-accountable.com/tag/bristol-myers-squibb/2026-08-20T21:07:37.000Zhttps://www.reasonably-accountable.com/tag/non-inferiority/2026-08-20T21:07:37.000Z